BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Tongli Pharmaceuticals (USA) Signed New Distribution Agreement With Shandong Shanglian Biochemical Medicine Limited Company


3/22/2011 6:44:59 AM

HARBIN, China, March 22, 2011 /PRNewswire/ -- Tongli Pharmaceuticals (USA) Inc. (OTC Bulletin Board: TGLP), announced today that the company signed new distribution agreement with Shandong Shanglian Biochemical Medicine Limited Company. Five of our products including Antihyperlipidemics, Calcium Gluconate Oral Liquid, Panax and Radix Polygoni Capsule, Metformin Hydrochloride Tablets, Clindamycin Hydrochloride will be sold at four cities (Zibo, Weifang, Linyi and Liaocheng) of Shandong Province. As of 2010, the total sales of medicine industry in these four cities was RMB 40 Billion ($6 Billion). This is the first time that our products will be sold in Shandong Province. Company expects it a positive factor in boosting the company's revenue in 2011 significantly.

Mr. Mingli Yao, Chairman and CEO commented, "We're happy to have the great opportunity to cooperate with Shandong Shanglian Biochemical Medicine Limited Company. We feel this reflects a growing interest in our company based on our continued ability to implement our business strategies and drive Tongli's revenues and profits. We expect our products will be sold to more cities in Shandong Province in the near future."

About Tongli Pharmaceuticals (USA) Inc.

Tongli Pharmaceuticals (USA) Inc. is a pharmaceutical company located in Harbin, China. The Company's manufacturing facilities are GMP certified in China, engaged in producing a range of prescription and over-the-counter products.

About Shandong Shanglian Biochemical Medicine Limited Company.

Shandong Shanglian Biochemical Medicine Limited Company is one of the largest medicine wholesale and retail companies in Shandong Province. It has thousands of chain stores and retail stores all over the Shandong Province.

Cautionary Note Regarding Forward Looking Statements

Statements made in this press release that are not of historical in nature are forward-looking and are pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause actual results to differ materially from those set forth in these statements. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise.

SOURCE Tongli Pharmaceuticals (USA) Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES